Robert A Schoevers
Overview
Explore the profile of Robert A Schoevers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
7708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solis E, Carlier I, Schoevers R, Penninx B, van Hemert A, van der Does A
Int J Psychiatry Clin Pract
. 2025 Mar;
:1-9.
PMID: 40089852
Objective: Cognitive Reactivity (CR) is the (re-)activation of negative cognitions by dysphoric mood. We examined whether CR predicts depressive episodes across 2 and 9 years, beyond subclinical depressive symptoms, neuroticism,...
2.
Veraart J, Smith-Apeldoorn S, Kamphuis J, Touw D, Schoevers R
Eur J Pharmacol
. 2025 Mar;
:177470.
PMID: 40058750
Objective: Oral esketamine has relatively low and variable bioavailability, which may complicate broader use as an antidepressant. This study aimed to investigate associations between different pharmacokinetic outcomes and change in...
3.
Kamstra A, de Vries S, Brilman M, Vasilev P, Alma M, van Asselt A, et al.
Front Psychiatry
. 2025 Feb;
16:1538267.
PMID: 39975947
Introduction: Childhood traumatization can result in physical and mental health problems in adulthood, such as post-traumatic stress disorder (PTSD), which negatively influences quality of life and social functioning. Although evidence...
4.
Coerts D, Veraart J, Kamphuis J, Smith-Apeldoorn S, Schoevers R, van Belkum S
J ECT
. 2025 Jan;
PMID: 39853300
Objectives: This study investigates repeated oral esketamine as a substitution strategy for maintenance electroconvulsive therapy (M-ECT) in eight patients with treatment-resistant depression (TRD). Methods: In a 6-week dosing phase, esketamine...
5.
Turkmen C, Machunze N, Lee A, Bougelet E, Ludin N, de Cates A, et al.
J Am Acad Child Adolesc Psychiatry
. 2025 Jan;
PMID: 39828036
Objective: To examine the association between newer generation antidepressants and insomnia as an adverse event (AE) in the treatment of children and adolescents with major depressive disorder (MDD). Method: A...
6.
Lima Constantino J, Godschalk M, van Dalfsen J, Veraart J, Spijker J, van Exel E, et al.
Psychiatry Res
. 2025 Jan;
345:116355.
PMID: 39813859
Accumulating evidence supports the efficacy of (es)ketamine in the treatment of major depressive disorder (MDD), particularly treatment-resistant depression (TRD). Yet around 50% of the individuals with TRD do not respond...
7.
Lima Constantino J, van Dalfsen J, Massetti S, Kamphuis J, Schoevers R
Prog Neuropsychopharmacol Biol Psychiatry
. 2025 Jan;
136():111251.
PMID: 39788410
Psilocybin represents a novel therapeutic approach for individuals with major depressive disorder (MDD) who do not respond to conventional antidepressant treatment. Investigating the influence of psilocybin on the pathophysiological processes...
8.
Loef D, Argyelan M, Ruhe H, Scheepens D, Schoevers R, Tendolkar I, et al.
Neuropsychopharmacology
. 2025 Jan;
PMID: 39762574
Electroconvulsive therapy (ECT) is an effective treatment for depression but is often associated with cognitive side effects. In patients, ECT-induced electric field (E-field) strength across brain regions varies significantly due...
9.
Goodwin G, Aaronson S, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, et al.
J Affect Disord
. 2024 Dec;
372():523-532.
PMID: 39706482
Objective: To determine the relationships between psilocybin dose, psychedelic experiences, and therapeutic outcome in treatment-resistant depression. Methods: For treatment-resistant depression, 233 participants received a single dose of 25, 10, or...
10.
Seybert C, Schimmers N, Silva L, Breeksema J, Veraart J, Bessa B, et al.
Lancet Psychiatry
. 2024 Dec;
12(1):54-66.
PMID: 39667373
Although studies of psychedelic-assisted psychotherapy are accumulating, there is no consensus regarding best practice of the psychotherapeutic component. In this systematic review, we summarised the quality of reporting on psychological...